A decline in cholinergic function and diminished expression of the cholinergic marker, CHAT, is apparent in aged humans and animals [130,131,132], in patients with Alzheimer’s disease (AD) [133,134,135,136], and in animal models of AD [118,123,124,125,126,127,128,135,137]. The gene discussed is CHAT; the disease is Alzheimer disease.